Alzheimer's agitation drug safety study halted early
NCT ID NCT06736509
First seen Feb 23, 2026 · Last updated May 14, 2026 · Updated 13 times
Summary
This study looked at the long-term safety of a drug called AXS-05 for treating agitation in people with Alzheimer's disease. It included 139 participants who had already completed earlier studies. The main goal was to track side effects over time. The study was terminated early, so results may be limited.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ALZHEIMER DISEASE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Clinical Research Site
Peoria, Arizona, 85381, United States
-
Clinical Research Site
Walnut Creek, California, 94596, United States
-
Clinical Research Site
Bonita Springs, Florida, 34134, United States
-
Clinical Research Site
Brandon, Florida, 33511, United States
-
Clinical Research Site
Greenacres City, Florida, 33467, United States
-
Clinical Research Site
Hialeah, Florida, 33012, United States
-
Clinical Research Site
Miami, Florida, 33126, United States
-
Clinical Research Site
Miami, Florida, 33145, United States
-
Clinical Research Site
Miami, Florida, 33155, United States
-
Clinical Research Site
Miami, Florida, 33165, United States
-
Clinical Research Site
Miami, Florida, 33173, United States
-
Clinical Research Site
Miami Gardens, Florida, 33014, United States
-
Clinical Research Site
Miami Lakes, Florida, 33014, United States
-
Clinical Research Site
Pembroke Pines, Florida, 33025, United States
-
Clinical Research Site
Tampa, Florida, 33614, United States
-
Clinical Research Site
Tampa, Florida, 33634, United States
-
Clinical Research Site
Braintree, Massachusetts, 02184, United States
-
Clinical Research Site
Brooklyn, New York, 11229, United States
-
Clinical Research Site
Charlotte, North Carolina, 28211, United States
-
Clinical Research Site
Mesquite, Texas, 75149, United States
-
Clinical Research Site
Arlington, Virginia, 22205, United States
-
Clinical Research Site
San Juan, 00918, Puerto Rico
Conditions
Explore the condition pages connected to this study.